Pharmacy
Lars Rebien Sørensen to retire as CEO of Novo Nordisk
The FINANCIAL -- Novo Nordisk A/S on September 1 announced that Lars Rebien Sørensen, president and chief executive officer, will...
XALKORI Receives Approval In European Union For The Treatment Of Patients With ROS1-Positive Advanced Non-Small Cell Lung Cancer
The FINANCIAL -- Pfizer Inc. on August 31 announced that the European Commission has approved XALKORI (crizotinib) for the treatment...
AstraZeneca provides update on Phase III trial of Selumetinib in non-small cell lung cancer
The FINANCIAL -- AstraZeneca on August 9 announced results from the Phase III SELECT-1 trial of the MEK 1/2 inhibitor,...
Pfizer Announces Publication Of New Data From Studies Of Vyndaqel
The FINANCIAL -- Pfizer Inc. announced the publication of a new post-hoc analysis of data from three studies of VYNDAQEL...
Novo Nordisk increased adjusted operating profit by 8% in local currencies
The FINANCIAL -- Operating profit decreased by 3% reported in local currencies and by 6% in Danish kroner to DKK...
Teva Announces Acquisition of Anda Inc.
The FINANCIAL -- Teva Pharmaceutical Industries Ltd., on August 3 announced that it has entered into a definitive agreement to...
Amgen And Advaxis Enter Global Cancer Immunotherapies Collaboration
The FINANCIAL -- Amgen and Advaxis, Inc. on August 2 announced a global agreement for the development and commercialization of...
Pfizer To Acquire Gene-Tech Company
The FINANCIAL -- Pfizer Inc. on August 1 announced that it has acquired Bamboo Therapeutics, Inc., a privately held biotechnology...
GSK and Verily to establish Galvani Bioelectronics
The FINANCIAL -- GSK on August 1 announced an agreement with Verily Life Sciences LLC (formerly Google Life Sciences), an...
Alcon launches Dailies Total1 Multifocal contact lenses, the first and only water gradient lenses designed for people with presbyopia
The FINANCIAL -- Alcon, one of the global leaders in eye care and a division of Novartis, introduces Dailies Total1...
Pfizer Receives FDA Approval for Prevnar 13 in Adults Age 18 Through 49
The FINANCIAL -- Pfizer Inc. on July 12 announced that Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine ) received U.S. Food...
FDA Approves First And Only Single Monthly Injection For A PCSK9 Inhibitor
The FINANCIAL -- Amgen on July 11 announced that the U.S. Food and Drug Administration (FDA) has approved the Repatha...
Takeda Receives European Commission Approval of ADCETRIS
The FINANCIAL -- Takeda Pharmaceutical Company Limited on July 6 announced that the European Commission (EC) has extended the current...
FDA Approves Abbott Absorbable Stent For Coronary Artery Disease
The FINANCIAL -- Abbott announced on July 5 that the U.S. Food and Drug Administration has approved the company's Absorb...
Biogen And AbbVie’s Once-Monthly ZINBRYTA Approved In EU To Treat MS
The FINANCIAL -- The European Commission (EC) has granted marketing authorization for ZINBRYTA (daclizumab) for the treatment of adult patients...
ADVERTISEMENT
Popular Last 24h
-
RFE/RL: Letter from Congress Urges U.S. Secretary of State Nominee Marco Rubio to Sanction Ivanishvili’s “Enablers”
-
What time is SpaceX’s Starship Flight 7 launch test on Jan. 13?
-
Scope Ratings Revised the Republic of Georgia’s Credit Ratings and Outlooks to Negative
-
Governor Newsom signs executive order to help Los Angeles rebuild faster and stronger
-
Real Estate in Focus: 2025 Trends to Watch
-
Most international migrants don’t move very far from their home countries
-
Iran congratulates Maduro on inauguration, pledges closer ties with Venezuela
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
